Results 211 to 220 of about 51,709 (292)

Revamping Parkinson's disease therapy using PLGA-based drug delivery systems. [PDF]

NPJ Parkinsons Dis
Lababidi JM, Azzazy HME.
europepmc   +1 more source

Validity of the elastase assay in intensive care medicine [PDF]

, 1988
Fritz, Hans, Jochum, Marianne, Lang, H., Redl, H., Redl, H., Schlag, G.   +5 more
core  

Effects of dopamine on reducing salt stress damage in pepper (Capsicum annuum L.) at morphological, physiological, biochemical, and molecular levels

Annals of Applied Biology, EarlyView.
Salt stress causes oxidative and osmotic stress, resulting in decreased nutrient uptake, plant growth, and photosynthetic rate. This study suggests that foliar application of dopamine can reduce salinity‐induced oxidative damage in pepper plants by altering antioxidant activity, biochemical, and molecular responses.
Sumeyra Ucar, Esra Yaprak, Melek Ekinci, Merve Yuce, Murat Aydin, Metin Turan, Esma Yigider, Guleray Agar, Melike Akca, Simona Ioana Vicas, Ertan Yildirim   +10 more
wiley   +1 more source

Striatal dopamine synthesis capacity in Parkinson's disease: Effects of age, sex, and body mass index in a large [¹⁸F]fluorodopa PET cohort. [PDF]

Neuroimage Clin
Malén T, Tuisku J, Bucci M, Santavirta S, Kaasinen V, Kaasalainen S, Isojärvi J, Hietala J, Rinne J, Nummenmaa L.   +9 more
europepmc   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

A Unique Case of Metastatic Paraganglioma in a Patient With Parkinson Disease. [PDF]

JCEM Case Rep
Aye ST, Oo TD, Lwin NA.
europepmc   +1 more source

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, EarlyView.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source

Preclinical Catecholaminergic Biomarkers of Central Lewy Body Diseases. [PDF]

J Clin Neurol
Goldstein DS.
europepmc   +1 more source

Hippocampal subfield differences in people with and without recreational ketamine use: Insights from multi‐modal neuroimaging

Addiction, EarlyView.
Abstract Background and aims Recreational ketamine use has increased globally and is associated with psychiatric and cognitive concerns. The hippocampus in preclinical models shows damage and working‐memory disruption with repeated dosing. However, whether specific hippocampal subregions may differ in people with chronic ketamine use remains unclear ...
Yi‐Hsuan Liu, Chia‐Chun Hung, Marc N. Potenza, Kun‐Hsien Chou, Pei‐Lin Lee, Chu‐Chung Huang, Chiang‐Shan R. Li, Tony Szu‐Hsien Lee, Ching‐Po Lin   +8 more
wiley   +1 more source

Multiplexed neurochemical monitoring reveals glutamate modulates dopamine neurotransmission in the nucleus accumbens. [PDF]

Neurochem Int
Donarski ED, Connors SS, Venton BJ.
europepmc   +1 more source